Gesellschaftsrecht / M&A

Steuern

Prozesse

Wettbewerb

IP / IT

Homburger News

Homburger and Danaher

On August 19, 2024, Genedata AG announced that it has been acquired by Danaher Corporation (NYSE: DHR), a leading global life science and diagnostic innovator.
Founded in 1997 and headquartered in Basel, Switzerland, Genedata is at the forefront of transforming data into intelligence for the life sciences industry. It delivers scalable and open solutions that enhance R&amp;D productivity, serving top global biopharmaceutical companies and innovative biotechnology organizations around the globe.
The Homburger team advising Danaher comprised Stefan Blunschi, Heinz Schärer, Oriana Schöni, Marilena Balthasar and Paula Delissen (all Corporate / M&amp;A), Reto Heuberger and Philippe Weber (both Tax), Mariella Orelli (Litigation), Richard Stäuber (Competition) and Joel Fink (IP / IT).

Homburger advised Danaher Corporation on its acquisition of Genedata AG

Finanzierungen und Anlageprodukte

Kapitalmarkt

Roche

On November 3, 2021, Roche Holding AG as borrower entered into a CHF 9,814 bn and USD 10 bn bridge facility agreement with BNP Paribas S.A. and Deutsche Bank AG each as Arranger, Deutsche Bank Luxembourg S.A. as Agent and a syndicate of international banks as Lenders.
On December 13, 2021, Roche Holdings, Inc. successfully completed its issuance of USD 2 bn 1.930% Notes due 2028, USD 2 bn 2.076% Notes due 2031 and USD 2 bn 2.607% Notes due 2051, which are irrevocably and unconditionally guaranteed by Roche Holding AG.
The borrowings under the Bridge Facility have been, and the net proceeds from the issuance of the Notes are expected to be, used in connection with Roche Holding AG&#8217;s repurchase of 53.3 m of its shares from Novartis Holding AG.
Homburger advised Roche on all Swiss law aspects of the transaction. The Homburger team was led by partner Jürg Frick (Financing and Investment Products / Capital Markets), and included partners Heinz Schärer (Corporate / M&amp;A), David Oser (Corporate / M&amp;A), Stefan Oesterhelt (Tax) and Dieter Grünblatt (Tax), counsel Lee Saladino (Capital Markets) and Micha Fankhauser (Corporate / M&amp;A), and associates Sofiya Shavlak (Capital Markets) and Stefan Bindschedler (Financing and Investment Products).

Homburger advises Roche Holding AG on the financing of the repurchase of the Novartis stake in Roche Holding

On November 4, 2021, Roche Holding AG (Roche), the world&#8217;s largest biotech company, with a market capitalisation of around CHF 320 bn, announced that it agreed with Novartis to repurchase 53.3 m Roche shares from Novartis Holding AG for an aggregate consideration of approx. CHF 19 bn. The transaction is conditional upon the approval of a capital reduction by cancellation of the repurchased shares and the approval of interim financial statements prepared for the purpose of the transaction by an extraordinary general meeting of Roche.
Homburger acted as legal counsel to Roche. The Homburger team was led by partners Heinz Schärer and David Oser and included partner Daniel Häusermann, counsel Micha Fankhauser, associates Sarah Chevalley and Jasmin Künzle (all Corporate / M&amp;A), partners Reto Heuberger and Dieter Grünblatt and associates Laetitia Fracheboud and Kevin Müller (all Tax), partner Jürg Frick, counsels Lee Saladino and Eduard De Zordi and associate Stefan Bindschedler (all Finance), partner Balz Gross, counsel Bénédict Thomann and associates Luca Angstmann and Sebastian Wyler (all Dispute Resolution).

Homburger advises Roche Holding AG on the repurchase of the Novartis stake in Roche Holding AG and the financing of the transaction 

Er arbeitet vorwiegend auf den Gebieten Firmenkäufe und -zusammenschlüsse (M&amp;A), öffentliche Übernahmen, Joint Ventures, Venture-Capital- und Private-Equity-Transaktionen, Gesellschafts- und Kapitalmarktrecht sowie Unternehmensfinanzierungen. Er ist ein von der SIX Swiss Exchange anerkannter Emittentenvertreter.
Heinz Schärer ist Mitglied des Vorstandes der Zürcher Handelskammer, Mitglied der International Bar Association und Verwaltungsrat in mehreren privat gehaltenen Gesellschaften.

Heinz
Schärer

Homburger advised Danaher Corporation on its acquisition of Genedata AG

Homburger advises Roche Holding AG on the financing of the repurchase of the Novartis stake in Roche Holding

Homburger advises Roche Holding AG on the repurchase of the Novartis stake in Roche Holding AG and the financing of the transaction

Chapter 8: Executive Management

Vom Übernahmerecht zum Übernahmeschutzrecht?

"Say on Pay" in der Schweizer Publikumsgesellschaft

Join the Team

Heinz Schärer

Karriere

Sprachen

Zulassung

Teams

HeinzSchärer

Homburger advised Danaher Corporation on its acquisition of Genedata AG

Homburger advises Roche Holding AG on the financing of the repurchase of the Novartis stake in Roche Holding

Homburger advises Roche Holding AG on the repurchase of the Novartis stake in Roche Holding AG and the financing of the transaction

Chapter 8: Executive Management

Vom Übernahmerecht zum Übernahmeschutzrecht?

"Say on Pay" in der Schweizer Publikumsgesellschaft

Join the Team

Heinz Schärer

Karriere

Sprachen

Zulassung

Teams

Heinz
Schärer